Synergistic mechanisms of retigeric acid B and azoles against Candida albicans

Journal of Applied Microbiology

Volumn 108, Issue 1, 2010, Pages 341-348

  Sun, L M ^a   Cheng, A X ^a   Wu, X Z ^a   Zhang, H J ^a   Lou, H X ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

CDR1; ERG11; Ergosterol; Retigeric acid B; Rhodamine 123

Indexed keywords

ALCOHOLS; CANDIDA; CYTOLOGY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; POLYMERASE CHAIN REACTION; SPECTROPHOTOMETERS; SPECTROPHOTOMETRY; YEAST;

ALBICANS; ANTIFUNGALS; CANDIDA ALBICANS; CDR1; ERG11; ERGOSTEROL; RETIGERIC ACID B; RHODAMINE 123; SPECTRO-PHOTOMETRIC METHOD; SYNERGISTIC MECHANISM;

BIOCHEMISTRY;

ANTIFUNGAL AGENT; PYRROLE DERIVATIVE; RETIGERIC ACID B; RHODAMINE 123; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BIOTECHNOLOGY; DRUG; ERGOSTEROL; FUNGUS; LICHEN; ORGANIC COMPOUND; POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; TRANSMISSION ELECTRON MICROSCOPY;

ARTICLE; CANDIDA ALBICANS; CDR1 GENE; CELL MEMBRANE; CELL WALL; DOWN REGULATION; DRUG MECHANISM; DRUG POTENTIATION; ERG11 GENE; FLOW CYTOMETRY; FUNGAL GENE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; TRANSMISSION ELECTRON MICROSCOPY;

CANDIDA ALBICANS;

EID: 72449207612     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2009.04429.x     Document Type: Article

References (21)

1. Arthington-Skaggs, B.A., Jradi, H., Desai, T. Morrison, C.J. (1999) Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 37, 3332 3337.
2. Ball, A.R., Casadei, G., Samosorn, S., Bremner, J.B., Ausubel, F.M., Moy, T.I. Lewis, K. (2006) Conjugating berberine to a multidrug resistance pump inhibitor creates an effective antimicrobial. ACS Chem Biol 1, 594 600.
3. Calderone, R.A. Fonzi, W.A. (2001) Virulence factors of Candida albicans. Trends Microbiol 9, 327 335.
4. Coste, A., Turner, V., Ischer, F., Morschhauser, J., Forche, A., Selmecki, A., Berman, J., Bille, J. et al. (2006) A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172, 2139 2156.
5. Cowen, L.E., Sanglard, D., Calabrese, D., Sirjusingh, C., Anderson, J.B. Kohn, L.M. (2000) Evolution of drug resistance in experimental populations of Candida albicans. J Bacteriol 182, 1515 1522.
6. Guo, X.L., Leng, P., Yang, Y., Yu, L.G. Lou, H.X. (2008) Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump. J Appl Microbiol 104, 831 838.
7. Henry, K.W., Nickels, J.T. Edlind, T.D. (2000) Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 44, 2693 2700.
8. Hiller, D., Sanglard, D. Morschhäuser, J. (2006) Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans. Antimicrob Agents Chemother 50, 1365 1371.
9. Kohli, A., Smriti, Mukhopadhyay, K., Rattan, A. Prasad, R. (2002) In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob Agents Chemother 46, 1046 1052.
10. Löffler, J., Einsele, H., Hebart, H., Schumacher, U., Hrastnik, C. Daum, G. (2000) Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol Lett 185, 59 63.
11. Mukherjee, P.K., Chandra, J., Kuhn, D.M. Ghannoum, M.A. (2003) Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71, 4333 4340.
12. Mukhopadhyay, K., Kohli, A. Prasad, R. (2002) Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob Agents Chemother 46, 3695 3705.
13. Mukhopadhyay, K., Prasad, T., Saini, P., Pucadyil, T.J., Chattopadhyay, A. Prasad, R. (2004) Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrob Agents Chemother 48, 1778 1787.
14. National Committee for Clinical Laboratory Standards (NCCLS) 2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts approved standard. NCCLS document M27-A2. Wayne, PA, USA : NCCLS.
15. Pasrija, R., Panwar, S.L. Prasad, R. (2008) Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts. Antimicrob Agents Chemother 52, 694 704.
16. Prasad, T., Chandra, A., Mukhopadhyay, C.K. Prasad, R. (2006) Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-sensitive cells. Antimicrob Agents Chemother 50, 3597 3606.
17. Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E. Trautmann, M. (1994) Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 32, 2092 2098.
18. Schuetzer-Muehlbauer, M., Willinger, B., Egner, R., Ecker, G. Kuchler, K. (2003) Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. Int J Antimicrob Agents 22, 291 300.
19. Shukla, S., Saini, P., Smriti, Jha, S., Ambudkar, S.V. Prasad, R. (2003) Functional characterization of Candida albicans ABC transporter Cdr1p. Eukaryot Cell 2, 1361 1375.
20. Sun, L.M., Sun, S.J., Cheng, A.X., Wu, X.Z., Zhang, Y. Lou, H.X. (2009) In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans. Antimicrob Agents Chemother 53, 1586 1591.
21. Vanden Bossche, H., Marichal, P. Odds, F.C. (1994) Molecular mechanisms of drug resistance in fungi. Trends Microbiol 2, 393 400.